QUADRANT CAPITAL GROUP LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,624
-29.8%
106
-19.7%
0.00%
Q2 2023$3,739
+89.2%
132
+53.5%
0.00%
Q1 2023$1,976
-2.3%
86
+19.4%
0.00%
Q4 2022$2,022
-81.6%
72
-81.1%
0.00%
-100.0%
Q3 2022$11,000
+37.5%
381
+3.8%
0.00%0.0%
Q2 2022$8,000
+700.0%
367
+773.8%
0.00%
Q1 2022$1,0000.0%42
+7.7%
0.00%
Q4 2021$1,000
-75.0%
39
-59.8%
0.00%
-100.0%
Q3 2021$4,000
-20.0%
97
+12.8%
0.00%0.0%
Q2 2021$5,000
+25.0%
860.0%0.00%0.0%
Q1 2021$4,0000.0%860.0%0.00%0.0%
Q4 2020$4,000
+300.0%
86
+168.8%
0.00%
Q3 2020$1,0000.0%32
+68.4%
0.00%
Q2 2020$1,000
-95.2%
19
-96.8%
0.00%
-100.0%
Q1 2020$21,000
-4.5%
589
+24.3%
0.00%
+33.3%
Q4 2019$22,000474
+4209.1%
0.00%
Q2 2019$0
-100.0%
11
-90.5%
0.00%
-100.0%
Q1 2019$7,000116
+625.0%
0.00%
Q4 2015$0
-100.0%
16
-84.0%
0.00%
-100.0%
Q3 2015$5,000
+400.0%
100
+525.0%
0.00%
+200.0%
Q2 2015$1,000160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 965,369$56,378,00014.98%
Casdin Capital, LLC 237,500$13,870,0008.18%
BB BIOTECH AG 2,839,528$165,828,0005.42%
Opaleye Management Inc. 130,000$7,592,0003.78%
Redmile Group, LLC 902,578$52,711,0003.42%
Clarius Group, LLC 109,230$6,379,0002.63%
Opus Point Partners Management, LLC 57,410$3,353,0002.49%
Ghost Tree Capital, LLC 125,000$7,300,0001.36%
CAPITAL INTERNATIONAL LTD /CA/ 346,937$20,261,0001.32%
Eventide Asset Management 300,800$17,567,0001.16%
View complete list of AGIOS PHARMACEUTICALS INC shareholders